John Hathaway - 30 Jun 2025 SCHEDULE 13G/A Report for Medicus Pharma Ltd. Common shares, no par value (MDCX)

Filing Manager: John Hathaway
Reporting Manager: John Hathaway
Security: Medicus Pharma Ltd. Common shares, no par value
Symbol: MDCX
Shares outstanding: 17.8M shares
Disclosed Ownership: 801K shares
Ownership: 4.5%
Form type: SCHEDULE 13G/A
Filing time: 12 Aug 2025, 09:00:09 UTC
Date of event: 30 Jun 2025
Previous filing: 10 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
John Hathaway	4.5%	801K	801K	0	/s/ John Hathaway	John Hathaway
SkinJect Partners LLC	4.5%	801K	801K	0	/s/ John Hathaway	John Hathaway, Managing Director